FDA limits drugmaker liability in label revamp

WASHINGTON (Reuters) - U.S. health officials issued controversial language stating that federally approved drug labels pre-empt state liability laws as part of a revamp of the lengthy, hard-to-read instructions that come with medicines.

Continue to FDA limits drugmaker liability in label revamp on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz